Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nuvation Bio Inc shares valued at $17,100 were purchased by Markel Stacy on Jun 18 ’25. At $1.71 per share, Markel Stacy acquired 10,000 shares. The insider’s holdings grew to 29,591 shares worth approximately $60661.549999999996 following the completion of this transaction.
Also, Sauvage Philippe purchased 4,000 shares, netting a total of over 7,160 in proceeds. Following the buying of shares at $1.79 each, the insider now holds 9,902 shares.
Before that, Sauvage Philippe had added 3,300 shares to its account. In a trade valued at $6,056, the Chief Financial Officer bought Nuvation Bio Inc shares for $1.83 each. Upon closing the transaction, the insider’s holdings increased to 3,300 shares, worth approximately $12099.099999999999.
As published in their initiating research note from Citizens JMP on April 23, 2025, Nuvation Bio Inc [NUVB] has been a Mkt outperform and the price target has been revised to $6. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late March. As of March 26, 2024, BTIG Research has increased its “Neutral” rating to a “Buy” for NUVB. Earlier on January 06, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for NUVB stock which previously was a “a Buy”.
Analyzing NUVB Stock Performance
On last trading session,, Nuvation Bio Inc [NYSE: NUVB] rose 5.67% to $2.05. The stock’s lowest price that day was $1.9, but it reached a high of $2.07 in the same session. During the last five days, there has been a surge of approximately 9.04%. Over the course of the year, Nuvation Bio Inc shares have dropped approximately -29.79%. Shares of the company reached a 52-week high of $3.4500 on 01/07/25 and a 52-week low of $1.5400 on 04/07/25.
Support And Resistance Levels for Nuvation Bio Inc (NUVB)
According to the 24-hour chart, there is a support level at 1.9400, which, if violated, would cause prices to drop to 1.8400. In the upper region, resistance lies at 2.1100. The next price resistance is at 2.1800. RSI (Relative Strength Index) is 49.92 on the 14-day chart, showing neutral technical sentiment.
Is Nuvation Bio Inc subject to short interest?
Stocks of Nuvation Bio Inc saw a sharp rise in short interest on 2025-06-13 jumping by 18.25 million shares to 56.08 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 37.83 million shares. A jump of 32.54% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.86 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.86.
Which companies own the most shares of Nuvation Bio Inc (NUVB)?
In terms of Nuvation Bio Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 209.28% from the previous closing price of $1.94. Analysts anticipate Nuvation Bio Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 4 analysts ranked Nuvation Bio Inc stock as Buy at the end of 2025.
